This section addresses any adverse environmental effects not covered in the previous subsections of Section 12. It includes information on atmospheric effects, impacts on water systems, ecosystem effects, and other environmental concerns that may be relevant for risk assessment and management.
Chemicals can impact the atmosphere through various mechanisms, potentially affecting air quality, climate, and the ozone layer:
Several regulations address specific environmental effects:
| Parameter | Value | Classification | Regulatory Significance |
|---|---|---|---|
| Ozone Depletion Potential (ODP) | 0 | None | Not regulated under Montreal Protocol |
| Global Warming Potential (GWP) | < 1 | Not significant | Not considered a greenhouse gas |
| Photochemical Ozone Creation Potential (POCP) | 15 (relative to ethylene = 100) | Low potential | Limited contribution to smog formation |
| Atmospheric half-life | 2 days | Short-lived | Rapid degradation in atmosphere |
While individual effects may be minimal, combined effects with other substances should be considered in sensitive aquatic environments.
Endocrine disrupting properties require special attention under EU Regulation 2020/878:
Conclusion: The substance does not have endocrine disrupting properties based on available data.
Life Cycle Assessment (LCA) provides a comprehensive view of environmental impacts throughout a product's life cycle:
| Impact Category | Contribution | Notes |
|---|---|---|
| Climate Change | Low | Low GWP, minimal greenhouse gas emissions |
| Ozone Depletion | None | No ozone-depleting properties |
| Photochemical Ozone Formation | Low | Low POCP value |
| Acidification | Minimal | Limited contribution to acid rain formation |
| Eutrophication | Minimal | Limited impact on nutrient cycles |
| Resource Depletion | Moderate | Production requires non-renewable resources |
The overall environmental footprint of the substance is relatively low compared to similar substances in its class. The main environmental concerns are associated with production rather than use or disposal phases.
Based on the assessment of other adverse effects, the following risk management measures are recommended: